InvestorsHub Logo
Followers 40
Posts 1805
Boards Moderated 0
Alias Born 07/26/2019

Re: hayward post# 288957

Friday, 07/31/2020 1:25:53 PM

Friday, July 31, 2020 1:25:53 PM

Post# of 426434
Hayward
Agreed completely. You have the entirety of it. JT overreached and lost his chance. Why wonder why the share price languishes— the evidence overwhelms us:
1) No idea if the US market is gone to the generics: never ending legal saga with no end in sight
2) EU no clarity yet: slow walking approval completion. GIA vs. partnering vs licensing to someone else
3) Advertising limited maybe front loading the generics cause
4) MD’s have every reason to prescribe but how many know it?
5) Wondering if the time for being acquired passed and board of directors/ JT overreached and fell flat on their faces?
6) Shall I keep going.....?
How many but the faithful like these odds?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News